You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES


✉ Email this page to a colleague

« Back to Dashboard


POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Strides Pharma POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 204558 ANDA Strides Pharma Science Limited 64380-765-21 4 L in 1 JUG (64380-765-21) 2019-01-10
Strides Pharma POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 204558 ANDA Strides Pharma Science Limited 64380-766-21 4 L in 1 JUG (64380-766-21) 2019-01-10
Strides Pharma POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 204558 ANDA Strides Pharma Science Limited 64380-767-21 4 L in 1 JUG (64380-767-21) 2019-01-10
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Polyethylene Glycol 3350 and Electrolytes

Last updated: July 28, 2025


Introduction

Polyethylene glycol (PEG) 3350 combined with electrolytes is a widely used pharmaceutical formulation, primarily for bowel preparation prior to colonoscopies and other gastrointestinal procedures. Its formulation typically includes PEG 3350 and various electrolytes—sodium chloride, sodium bicarbonate, and potassium chloride—to ensure effective osmotic activity and electrolyte balance. The global market for PEG 3350 with electrolytes is highly competitive, comprising several suppliers ranging from large-scale chemical manufacturers to specialized contract manufacturers. This article offers a comprehensive analysis of the key suppliers, their geographic presence, manufacturing capabilities, and strategic positioning within this niche drug segment.


Global Market Overview

PEG 3350 with electrolytes holds a significant position within the gastrointestinal pharmaceutical market. Its popularity stems from proven efficacy, safety profile, and ease of use. The demand is driven by a growing number of diagnostic and therapeutic gastrointestinal procedures globally. Consequently, the supply chain depends on a reliable network of chemical and pharmaceutical manufacturers capable of producing high-quality PEG 3350 and electrolytes at scale.


Leading Suppliers of Polyethylene Glycol 3350 and Electrolytes

1. Brenntag AG

Overview: Brenntag is a global leader in chemical distribution with a strong foothold in specialty chemicals, including PEG 3350 and electrolytes. Their extensive distribution network ensures accessibility in North America, Europe, and Asia-Pacific.

Capabilities: Brenntag sources PEG 3350 from multiple manufacturers, providing customized formulations tailored to pharmaceutical requirements. They employ rigorous quality assurance processes aligned with pharmaceutical GMP standards.

Strategic Advantage: Brenntag’s geographic reach and extensive logistics capabilities make it a key supplier for pharmaceutical companies seeking reliable supply chain partners for PEG-based formulations.

2. BASF SE

Overview: As one of the largest chemical producers worldwide, BASF manufactures PEG derivatives, including PEG 3350, and supplies electrolytes for pharmaceutical applications.

Manufacturing Strengths: BASF’s advanced synthesis technologies ensure high purity PEG 3350, conforming to pharmacopeial standards such as USP and EP. The company emphasizes sustainability and quality control in production processes.

Applications: BASF’s PEG is used across pharmaceutical, cosmetic, and industrial sectors, with dedicated production lines for pharmaceutical grade material.

3. Citron Chemicals

Overview: Citron Chemicals specializes in the production of PEGs and derivative products, supplying both bulk chemicals and formulations to pharmaceutical manufacturers.

Positioning: Their focus on custom synthesis and high-quality standards makes them a preferred supplier for PEG 3350. They have established supply chains particularly across Asia and North America.

Certifications: Their manufacturing facilities carry GMP certifications, ensuring compliance with global pharmaceutical standards.

4. Fosun Pharma

Overview: As part of China’s leading pharmaceutical conglomerate, Fosun Pharma produces PEG-based excipients, including PEG 3350, for domestic and international markets.

Locational Advantage: With manufacturing plants in China and partnerships globally, Fosun Pharma offers competitive pricing coupled with reliable quality.

Market Focus: Their primary focus is on supplying PEG 3350 for gastrointestinal drug formulations, aligning with growing demand in the Asian markets.

5. Colorcon Inc. (a part of Ashland Inc.)

Overview: Although primarily known for excipient solutions, Colorcon distributes PEG 3350 used in solid formulation preparations, including bowel preparation drugs.

Supply Dynamics: They partner with multiple chemical manufacturers to source high-quality PEG 3350, emphasizing formulation stability and regulatory compliance.

Other Notable Suppliers

  • Dow Chemical Company: Produces PEG derivatives, serving the pharmaceutical industry with specialty PEG grades.
  • Ashland Global Holdings Inc.: Supplies PEG compounds used across pharmaceutical and consumer sectors.
  • FMC Corporation: Offers PEG-based excipients for various drug delivery systems.
  • Fresenius Kabi: Supplies electrolyte components and PEG formulations for medical applications.

Electrolyte Component Suppliers

Electrolyte ingredients are crucial for the efficacy of PEG-based bowel cleansers. Suppliers focus on high-purity compounds to prevent contamination or adverse reactions:

  • Fresenius Kabi: Supplies pharmaceutical-grade electrolytes, including sodium chloride, potassium chloride, and sodium bicarbonate.
  • Jubilant Life Sciences: Provides electrolyte salts for pharmaceutical formulations, emphasizing purity and batch-to-batch consistency.
  • Cambridge Isotope Laboratories: Offers isotopically pure electrolyte compounds for specialized applications.

Supply Chain Considerations

Regulatory compliance: Suppliers must ensure adherence to GMP, NSF, and pharmacopeial standards. Many leading suppliers possess certifications like ISO, GMP, and FDA registration to meet global regulatory requirements.

Quality assurance: Stringent quality control processes, including analytical testing and validation, underpin supplier credibility.

Pricing and availability: Large multinational suppliers benefit from economies of scale but may face geopolitical or logistical disruptions. Smaller specialized suppliers can offer niche formulations but may carry higher costs.

Partnerships & Alliances: Strategic collaborations, joint ventures, and long-term purchase agreements are common to ensure supply security.


Market Trends & Future Outlook

The ongoing development of generic drugs and biosimilars incorporating PEG 3350 with electrolytes continues to amplify demand. Innovations in formulation technology and a shift towards more sustainable manufacturing processes might redefine supplier strategies. Additionally, the expansion of markets in Asia-Pacific and Latin America presents opportunities for existing suppliers to broaden their footprint.

Continuous quality improvements, regulatory harmonization, and supply chain resilience will influence procurement decisions more than ever.


Key Takeaways

  • Diverse Supplier Landscape: The market includes both chemical giants like BASF and specialized distributors such as Brenntag, emphasizing options for pharmaceutical firms globally.
  • Quality & Compliance Focus: Regulatory standards drive supplier qualification, making GMP certification, purity levels, and proven track records essential criteria.
  • Supply Chain Resilience: Global disruptions highlight the importance of diversified sourcing and strategic partnerships.
  • Market Growth Drivers: Increasing gastrointestinal procedures and expanding global markets underpin sustained demand.
  • Innovation & Sustainability: Future suppliers will prioritize eco-friendly manufacturing and advanced formulation capabilities.

FAQs

1. Who are the leading global suppliers of PEG 3350 for pharmaceuticals?
Major suppliers include BASF, Brenntag, Citron Chemicals, and Fosun Pharma, all offering high-purity PEG 3350 in compliance with regulatory standards.

2. What key qualities should pharmaceutical companies consider when selecting a PEG 3350 supplier?
Regulatory compliance (GMP, pharmacopeial standards), purity levels, manufacturing capacity, logistical reliability, and certification credentials are critical factors.

3. Are there regional differences in PEG 3350 suppliers?
Yes. North American and European markets predominantly rely on local and regional suppliers; Asia-Pacific markets are served by manufacturers like Fosun Pharma and other Chinese suppliers.

4. How do electrolyte component suppliers influence the overall supply chain?
Electrolyte suppliers ensure high-purity salts essential for formulation efficacy, with quality and regulatory compliance directly impacting the performance and safety of PEG-based drugs.

5. What trends are shaping the future supply landscape for PEG 3350 and electrolytes?
Sustainable manufacturing, regulatory harmonization, growth in emerging markets, and technological advances in formulation are key trends influencing supplier strategies.


Conclusion

The supply landscape for polyethylene glycol 3350 combined with electrolytes features a diverse array of global manufacturing and distribution players. Ensuring reliable procurement hinges on rigorous supplier qualification processes, adherence to regulatory standards, and strategic partnerships accommodating future market growth. As demand escalates, especially in emerging markets, stakeholders must prioritize quality, supply security, and innovation to sustain their competitive edge in the gastrointestinal pharmaceutical sector.


References

  1. [1] Pharmeuropa and USP Monographs on PEG 3350.
  2. [2] BASF Annual Report 2022.
  3. [3] Brenntag’s Pharmaceutical Raw Material Portfolio.
  4. [4] Fosun Pharma’s Product Catalogs.
  5. [5] Market Research on Gastrointestinal Drugs and Supply Chain Dynamics.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.